Sage Therapeutics, Inc.
Neuroactive steroids, compositions, and uses thereof

Last updated:

Abstract:

Described herein are methods of treating a disorder, e.g., tremor, e.g., essential tremor; depression, e.g., postpostum depression; and anxiety disorder, the method comprising administering to a human subject suffering from a disorder, e.g., tremor, e.g., essential tremor; depression, e.g., postpostum depression, an anxiety disorder with a neuroactive steroid or a composition comprising a neuroactive steroid (e.g., pregnanolone, allopregnanolone, alphadalone, ganaxolone, or alphaxolone).

Status:
Grant
Type:

Utility

Filling date:

18 Dec 2019

Issue date:

9 Mar 2021